All In MedTech

Device Trial Radar · NCT07228221

Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma

iStent Infinite and iDose TR for Management of Moderate to Severe Primary Open Angle Glaucoma Are a Safe and Effective Alternative to Filtering Surgery for IOP Reduction in Patients With Medically Uncontrolled Glaucoma. (POAG)

Last checked: Nov 19, 2026Latest source record: Nov 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Jan 5, 2026

Primary completion

Aug 30, 2031

Study completion Dec 31, 2031

Sponsor

Lead sponsor
Jonathon MyersAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Glaukos Corporation
First posted
Nov 14, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.

Conditions

  • Open Angle Glaucoma
  • Pigmentary Glaucoma
  • Pseudoexfoliation Glaucoma

Interventions

  • iStent infinite trabecular micro-bypass system model iS3Device

    surgery perfomed using the iStent infinite trabecular micro-bypass system model iS3

  • iDose TR (Travoprost intracameral Implant) 75mcgDrug

    surgery performed using the iDose TR (Travoprost intracameral Implant) 75mcg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. IOP reduction from baselineTime frame: Diurnal IOP reduction from baseline at 12 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Wills Eye Hosital Glaucoma Dept.

    Philadelphia, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.